Analyst Ratings For NASDAQ:EXAS – EXACT Sciences (NASDAQ:EXAS)
Today, Robert W. Baird raised its price target on NASDAQ:EXAS – EXACT Sciences (NASDAQ:EXAS) to per share.
Some recent analyst ratings include
- 6/5/2018-BTIG Research Reiterated Rating of Buy.
- 5/31/2018-Canaccord Genuity Reiterated Rating of Buy ➝ Buy.
- 3/29/2018-William Blair Reiterated Rating of Buy.
- 2/23/2018-Benchmark was Downgraded by analysts at Benchmark from a “Buy ➝ Hold” rating to a “” rating.
- 1/29/2018-Goldman Sachs Group initiated coverage with a Neutral ➝ Neutral rating.
Recent Insider Trading Activity For NASDAQ:EXAS – EXACT Sciences (NASDAQ:EXAS)
NASDAQ:EXAS – EXACT Sciences (NASDAQ:EXAS) has insider ownership of 3.20% and institutional ownership of 89.10%.
- On 5/10/2018 Michael S Wyzga, Director, sold 7,402 with an average share price of $51.53 per share and the total transaction amounting to $381,425.06.
- On 4/12/2018 Katherine S Zanotti, Director, sold 7,232 with an average share price of $45.00 per share and the total transaction amounting to $325,440.00.
- On 4/10/2018 Thomas D Carey, Director, sold 8,448 with an average share price of $39.73 per share and the total transaction amounting to $335,639.04.
- On 4/2/2018 D Scott Coward, SVP, sold 2,122 with an average share price of $40.12 per share and the total transaction amounting to $85,134.64.
- On 3/12/2018 D Scott Coward, SVP, sold 2,708 with an average share price of $52.19 per share and the total transaction amounting to $141,330.52.
- On 3/12/2018 Kevin T Conroy, Insider, sold 11,459 with an average share price of $52.19 per share and the total transaction amounting to $598,045.21.
- On 3/12/2018 Maneesh Arora, COO, sold 5,295 with an average share price of $52.19 per share and the total transaction amounting to $276,346.05.
Recent Trading Activity for NASDAQ:EXAS – EXACT Sciences (NASDAQ:EXAS)
Shares of NASDAQ:EXAS – EXACT Sciences closed the previous trading session at 61.40 up +0.84 1.39% with 126133 shares trading hands.